Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1960 Jan 2;82(1):20–22.

Myocardial Infarction during Imipramine Treatment of Depression *

L Sloman
PMCID: PMC1937578  PMID: 13831702

Full text

PDF
20

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. KIELHOLZ P., BATTEGAY R. Behandlung depressiver Zustandsbilder, Unterspezieller Berücksichtigung von Tofranil, einem neuen Antidepressivum. Schweiz Med Wochenschr. 1958 Aug 2;88(31):763–767. [PubMed] [Google Scholar]
  2. LEHMANN H. E., CAHN C. H., DE VERTEUIL R. L. The treatment of depressive conditions with imipramine (G 22355). Can Psychiatr Assoc J. 1958 Oct;3(4):155–164. doi: 10.1177/070674375800300401. [DOI] [PubMed] [Google Scholar]
  3. MALITZ S., WILKENS B., ESECOVER H. Preliminary evaluation of tofranil in a combined in-patient and out-patient setting. Can Psychiatr Assoc J. 1959;4(Suppl):152–157. doi: 10.1177/070674375900401s15. [DOI] [PubMed] [Google Scholar]
  4. SARWER-FONER G. J., GRAUER H., MACKAY J., KORANYI E. K. Depressive states and drugs; a study of the use of imipramine tofranil in open psychiatric settings. Med Serv J Can. 1959 Jun;15(6):359–382. [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES